statements

GlaxoSmithKline Consumer Healthcare Ltd

NSE: GSKCONS

BSE: 500676

Sector:

Industry Group:

Industry:

10,732.60+0.0 (+0.00%)

20 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

GlaxoSmithKline Consumer Healthcare Ltd income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	C 2008 Dec 31	C 2009 Dec 31	2010 Dec 31	C 2011 Dec 31	2012 Dec 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	TTM Dec 31
	C 2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	C 2008 Dec 31	C 2009 Dec 31	2010 Dec 31	C 2011 Dec 31	2012 Dec 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	TTM Dec 31
Period length: Source:	12M PRESS	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	15M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	967	1,108	1,278	1,544	1,922	2,306	2,765	3,187	4,869	4,308	4,136	3,986	4,317	4,782	4,984
Cost of Operating Revenue	353	422	487	669	793	951	1,123	1,254	2,063	1,561	1,631	1,569	1,704	1,718	1,568
Gross Profit	614	686	792	875	1,129	1,355	1,642	1,934	2,805	2,746	2,506	2,418	2,613	3,064	3,417
Gross Margin	63.5	61.9	61.9	56.7	58.7	58.7	59.4	60.7	57.6	63.8	60.6	60.6	60.5	64.1	68.5
Total Operating Expenses	825	966	1,095	1,343	1,651	1,967	2,307	2,650	4,056	3,640	3,356	3,217	3,498	3,702	3,792
Operating Profit	142	142	184	201	270	339	458	537	813	668	781	769	819	1,080	1,193
Operating Margin	14.7	12.8	14.4	13.0	14.1	14.7	16.6	16.9	16.7	15.5	18.9	19.3	19.0	22.6	23.9
Financing Income/(Expense) - Net	-4	-4	19	31	20	40	67	96	182	-1	203	218	216	275	-5
Profit before Taxes	162	191	245	286	354	452	540	649	1,016	889	1,056	1,010	1,074	1,512	1,631
Income Taxes	55	64	82	97	121	152	185	212	341	306	369	354	374	529	412
Profit after Tax	107	127	163	188	233	300	355	437	675	584	687	657	700	983	1,156
PAT Margin	11.1	11.5	12.7	12.2	12.1	13.0	12.8	13.7	13.9	13.5	16.6	16.5	16.2	20.6	23.2
EPS - Basic - ex Extraordinary Items	24.83	30.18	38.68	44.78	55.35	71.30	84.46	103.85	160.44	138.77	163.42	156.15	166.47	233.69	289.97
EPS - Diluted - ex Extraordinary Items	24.83	30.18	38.68	44.78	55.35	71.30	84.46	103.85	160.44	138.77	163.42	156.15	166.47	233.69	289.97
EBIT	142	142	184	201	270	339	458	537	813	668	781	769	819	1,080	1,193
EBITDA	184	185	227	243	313	379	505	573	875	730	838	833	883	1,141	1,267
EBITDA Margin	19.0	16.7	17.8	15.8	16.3	16.4	18.2	18.0	18.0	16.9	20.3	20.9	20.5	23.9	25.4

Balance Sheet

Abridged

Understanding Balance Sheet

GlaxoSmithKline Consumer Healthcare Ltd balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	R 2008 Dec 31	2009 Dec 31	C 2010 Dec 31	R 2011 Dec 31	2012 Dec 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31
	C 2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	R 2008 Dec 31	2009 Dec 31	C 2010 Dec 31	R 2011 Dec 31	2012 Dec 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	402	298	371	853	1,173	1,423	1,642	2,057	2,754	3,306	3,758	4,139	4,562	5,267
Long-Term Investments	0	220	298	0	0	0	-	-	-	17	21	22	22	22
Property Plant & Equipment - Net	114	63	25	413	402	488	350	391	711	536	532	536	511	475
Total Non-Current Assets	524	699	748	421	423	523	440	497	997	715	738	816	851	801
Total Assets	691	779	918	1,091	1,429	1,772	2,082	2,554	3,411	4,022	4,495	4,955	5,413	6,068
Total Current Liabilities	183	209	249	312	511	800	878	1,105	1,432	1,401	1,457	1,596	1,743	1,814
Long Term Debt	-	-	-	-	-	-	-	-	-	7	2	-	-	-
Total Non-Current Liabilities	33	28	23	18	13	12	61	88	167	227	240	236	185	159
Total Liabilities	216	236	272	330	524	812	938	1,194	1,599	1,628	1,697	1,832	1,928	1,973
Total Shareholders' Equity	475	543	646	761	905	960	1,144	1,361	1,813	2,394	2,799	3,123	3,485	4,095
Total Equity	475	543	646	761	905	960	1,144	1,361	1,813	2,394	2,799	3,123	3,485	4,095
Total Liabilities & Equity	691	779	918	1,091	1,429	1,772	2,082	2,554	3,411	4,022	4,495	4,955	5,413	6,068

Cash Flow

Abridged

Understanding Cash Flow Statement

GlaxoSmithKline Consumer Healthcare Ltd cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	C 2008 Dec 31	C 2009 Dec 31	2010 Dec 31	R 2011 Dec 31	C 2012 Dec 31	C 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31
	2005 Dec 31	R 2006 Dec 31	R 2007 Dec 31	C 2008 Dec 31	C 2009 Dec 31	2010 Dec 31	R 2011 Dec 31	C 2012 Dec 31	C 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	15M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	136	153	222	213	250	314	421	488	809	765	737	701	624	949
Working Capital - Increase/(Decrease)	-33	-4	-14	-57	169	39	22	149	-46	19	15	98	283	-32
Net CF from Operating Activities	104	149	208	156	419	353	443	637	763	784	751	799	907	917
Capital Expenditures - Net	20	18	25	29	45	109	95	82	168	106	52	66	49	33
Net CF from Investing Activities	-20	-238	-45	-7	-45	-109	-181	-464	-391	157	-332	-801	-633	-581
Dividends Paid - Cash - Total	33	43	50	42	21	76	210	147	189	189	231	294	293	311
Stock - Issuance/(Retirement) - Net	-123	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Flow from Financing Activities	-161	-48	-59	-49	-25	-88	-245	-171	-221	-221	-283	-359	-361	-376
Free Cash Flow to Equity	84	130	183	126	374	244	348	555	595	678	699	733	858	884
Free Operating CF net dividend	49	87	132	83	351	163	135	406	405	487	466	437	563	571
Free Operating CF	83	129	183	125	373	239	346	553	594	677	697	731	856	883

Business Segment Analysis

GlaxoSmithKline Consumer Healthcare Ltd business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for GlaxoSmithKline Consumer Healthcare Ltd

Regional Segment Analysis

GlaxoSmithKline Consumer Healthcare Ltd geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for GlaxoSmithKline Consumer Healthcare Ltd

Historical Segment Analysis

Track how GlaxoSmithKline Consumer Healthcare Ltd segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for GlaxoSmithKline Consumer Healthcare Ltd

Frequently Asked Questions

What is the revenue of GlaxoSmithKline Consumer Healthcare Ltd?

The latest trailing twelve month revenue of GlaxoSmithKline Consumer Healthcare Ltd is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of GlaxoSmithKline Consumer Healthcare Ltd?

The latest trailing twelve month net profit (PAT) of GlaxoSmithKline Consumer Healthcare Ltd is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of GlaxoSmithKline Consumer Healthcare Ltd?

The operating margin of GlaxoSmithKline Consumer Healthcare Ltd is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of GlaxoSmithKline Consumer Healthcare Ltd?

The trailing twelve month Earnings Per Share (EPS) of GlaxoSmithKline Consumer Healthcare Ltd is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of GlaxoSmithKline Consumer Healthcare Ltd?

The debt-to-equity ratio of GlaxoSmithKline Consumer Healthcare Ltd stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of GlaxoSmithKline Consumer Healthcare Ltd?

The book value per share of GlaxoSmithKline Consumer Healthcare Ltd is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of GlaxoSmithKline Consumer Healthcare Ltd?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does GlaxoSmithKline Consumer Healthcare Ltd report consolidated or standalone financials?

GlaxoSmithKline Consumer Healthcare Ltd reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.